| Year |
Citation |
Score |
| 2017 |
King CP, Militello L, Hart A, St Pierre CL, Leung E, Versaggi CL, Roberson N, Catlin J, Palmer AA, Richards JB, Meyer PJ. Cdh13 and AdipoQ gene knockout alters instrumental and Pavlovian drug conditioning. Genes, Brain, and Behavior. PMID 28387990 DOI: 10.1111/Gbb.12382 |
0.542 |
|
| 2016 |
Gao J, Davis LK, Hart AB, Sanchez-Roige S, Han L, Cacioppo JT, Palmer AA. Genome-Wide Association Study of Loneliness Demonstrates a Role for Common Variation. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 27629369 DOI: 10.1038/Npp.2016.197 |
0.603 |
|
| 2015 |
van den Berg SM, de Moor MH, Verweij KJ, Krueger RF, Luciano M, Arias Vasquez A, Matteson LK, Derringer J, Esko T, Amin N, Gordon SD, Hansell NK, Hart AB, Seppälä I, Huffman JE, et al. Meta-analysis of Genome-Wide Association Studies for Extraversion: Findings from the Genetics of Personality Consortium. Behavior Genetics. PMID 26362575 DOI: 10.1007/S10519-015-9735-5 |
0.611 |
|
| 2015 |
de Moor MH, van den Berg SM, Verweij KJ, Krueger RF, Luciano M, Arias Vasquez A, Matteson LK, Derringer J, Esko T, Amin N, Gordon SD, Hansell NK, Hart AB, Seppälä I, et al. Meta-analysis of Genome-wide Association Studies for Neuroticism, and the Polygenic Association With Major Depressive Disorder. Jama Psychiatry. 72: 642-50. PMID 25993607 DOI: 10.1001/Jamapsychiatry.2015.0554 |
0.59 |
|
| 2015 |
Yarosh HL, Meda SA, de Wit H, Hart AB, Pearlson GD. Multivariate analysis of subjective responses to d-amphetamine in healthy volunteers finds novel genetic pathway associations. Psychopharmacology. 232: 2781-94. PMID 25843748 DOI: 10.1007/S00213-015-3914-1 |
0.512 |
|
| 2015 |
Hart AB, Lynch KG, Farrer L, Gelernter J, Kranzler HR. Which alcohol use disorder criteria contribute to the association of ADH1B with alcohol dependence? Addiction Biology. PMID 25828809 DOI: 10.1111/adb.12244 |
0.314 |
|
| 2014 |
Hart AB, Gamazon ER, Engelhardt BE, Sklar P, Kähler AK, Hultman CM, Sullivan PF, Neale BM, Faraone SV, de Wit H, Cox NJ, Palmer AA. Genetic variation associated with euphorigenic effects of d-amphetamine is associated with diminished risk for schizophrenia and attention deficit hyperactivity disorder. Proceedings of the National Academy of Sciences of the United States of America. 111: 5968-73. PMID 24711425 DOI: 10.1073/Pnas.1318810111 |
0.597 |
|
| 2013 |
Baggott MJ, Childs E, Hart AB, de Bruin E, Palmer AA, Wilkinson JE, de Wit H. Psychopharmacology of theobromine in healthy volunteers. Psychopharmacology. 228: 109-18. PMID 23420115 DOI: 10.1007/S00213-013-3021-0 |
0.521 |
|
| 2013 |
Hart AB, de Wit H, Palmer AA. Candidate gene studies of a promising intermediate phenotype: failure to replicate. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 802-16. PMID 23303064 DOI: 10.1038/Npp.2012.245 |
0.62 |
|
| 2013 |
Wardle MC, Hart AB, Palmer AA, de Wit H. Does COMT genotype influence the effects of d-amphetamine on executive functioning? Genes, Brain, and Behavior. 12: 13-20. PMID 23231539 DOI: 10.1111/Gbb.12012 |
0.55 |
|
| 2012 |
Hart AB, Engelhardt BE, Wardle MC, Sokoloff G, Stephens M, de Wit H, Palmer AA. Genome-wide association study of d-amphetamine response in healthy volunteers identifies putative associations, including cadherin 13 (CDH13). Plos One. 7: e42646. PMID 22952603 DOI: 10.1371/Journal.Pone.0042646 |
0.631 |
|
| 2012 |
Hart AB, de Wit H, Palmer AA. Genetic factors modulating the response to stimulant drugs in humans. Current Topics in Behavioral Neurosciences. 12: 537-77. PMID 22261702 DOI: 10.1007/7854_2011_187 |
0.604 |
|
| Show low-probability matches. |